Novo Nordisk Partners With OpenAI to Accelerate AI-Driven Drug Discovery
Novo Nordisk has partnered with OpenAI to enhance its drug discovery efforts using advanced AI tools, aiming to accelerate identification of new treatments.
Explore the latest developments shaping global business, from corporate giants to fast-growing startups. Our Business section delivers in-depth coverage of mergers and acquisitions, regulation and policy shifts, breakthrough technologies, and venture capital trends. Get timely updates, analysis and context on how companies innovate, compete and expand in a rapidly changing economy. Designed for professionals, investors and curious readers alike, this is your go-to source for understanding the forces that drive business decisions worldwide.
Novo Nordisk has partnered with OpenAI to enhance its drug discovery efforts using advanced AI tools, aiming to accelerate identification of new treatments.
Blue Origin has developed a system to extract oxygen from lunar soil, a breakthrough that could support future Moon bases. The technology also produces usable metals for construction.
Elon Musk is set to launch XChat on April 17, introducing an encrypted messaging platform integrated with X. The app will include calls, file sharing, and enhanced privacy features.
Alibaba confirmed it is behind a viral AI video model topping global leaderboards. The reveal highlights its growing role in the AI race.
OpenAI has raised $122 billion in a record-breaking funding round to accelerate AI development. The deal comes as expectations grow for a future public offering.
Apple’s third co-founder Ron Wayne says he still owns a 10% stake in the company despite exiting shortly after its founding. The claim has reignited debate over early ownership agreements.
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
A new viral toy, ‘Mystery Dumpling’, is rapidly gaining popularity, overtaking Labubu as the latest collectible trend. The surge is fueling investor interest in companies tied to the craze.
Novartis has agreed to acquire immunology biotech Excellergy for $2 billion, marking its second major deal in a week. The move strengthens its pipeline in next-generation allergy treatments.
OpenAI is shutting down its Sora video generation model, citing undisclosed reasons. Reports suggest the product may have been costing up to $15 million per day to operate.
Meta has introduced a new executive incentive program tied to a $9 trillion valuation target. The move underscores its aggressive push to lead the artificial intelligence race.
Kalshi has raised more than $1 billion in a new funding round, valuing the prediction market platform at $22 billion. The deal highlights growing investor interest in event-driven trading markets.
Nissan plans to export U.S.-built vehicles to Japan, joining Toyota and Honda in reversing traditional trade flows. The move reflects shifting global production strategies in the auto industry.
The European Union is set to introduce a new “EU Inc” company structure aimed at simplifying cross-border business operations. The initiative seeks to reduce regulatory friction for startups and investors across the bloc.
Nvidia and Uber announced plans to launch Level 4 autonomous robotaxis in 28 cities by 2028. The partnership aims to scale AI-powered self-driving fleets across major urban markets.